| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 21st January 2021 | Riccardo Perfetti | 465 | Exercise of derivative | $1.44 | $669.60 |
| 21st January 2021 | Riccardo Perfetti | 465 | Open or private sale | $20.30 | $9,439.50 |
| 20th January 2021 | Riccardo Perfetti | 465 | Exercise of derivative | $1.44 | $669.60 |
| 20th January 2021 | Riccardo Perfetti | 465 | Open or private sale | $21.08 | $9,802.20 |
| 19th January 2021 | Riccardo Perfetti | 465 | Open or private sale | $21.83 | $10,150.95 |
| 19th January 2021 | Riccardo Perfetti | 465 | Exercise of derivative | $1.44 | $669.60 |
| 8th January 2021 | Riccardo Perfetti | 300 | Open or private sale | $21.92 | $6,576.00 |
| 8th January 2021 | Riccardo Perfetti | 7,685 | Open or private sale | $23.18 | $178,138.30 |
| 8th January 2021 | Riccardo Perfetti | 7,985 | Exercise of derivative | $1.44 | $11,498.40 |
| 7th January 2021 | Riccardo Perfetti | 765 | Open or private sale | $21.88 | $16,738.20 |
Applied Therapeutics
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The company was founded by Shoshana Shendelman on January 20, 2016.
Ticker: APLT
Sector: Healthcare
Industry: Biotechnology
SEC Central Index Key (CIK): 1697532
Employees:
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
We weren't able to import Fundamental data from the SEC disclosure.
There were no Red Flags found
Fundamentals
We weren't able to import Fundamental data from the SEC disclosure.
News
Applied Therapeutics And The Murky World Of Biopharma Development
19th January 2021
Applied Therapeutics to be Added to NASDAQ Biotechnology Index
15th December 2020
Applied Therapeutics Reports Third Quarter 2020 Financial Results
12th November 2020